Future advances will require integrating time-series omics approaches with TCR/BCR sequencing, real-time imaging, and longitudinal sampling to capture the dynamic evolutionary trajectories of the tumor immune ecosystem with higher temporal resolution. The gene discussed is BCR; the disease is neoplasm.